ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

IOM appoints 22 to National Cancer Policy Forum.

July 1, 2005

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Controversial Dr. Rajika Medencica Sued By Patient; Hilton Head hospital Reviews His Practices

April 30, 1993

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

ASCO Strategic Plan Seeks To Increase Value to Members, Public

May 24, 2002